Small Cap Biotechnology ETFs focus on the smallest market segment of the biotechnology industry of the broad health care sector. These are firms with market caps below $2 billion and tend to be early-stage pharmaceutical developers with one or two drugs in their pipeline.
Click on the tabs below to see more information on Small Cap Biotechnology ETFs, including historical performance, dividends, holdings, expense ratios, technical indicators, analysts reports and more. Click on an ETF ticker or name to go to its detail page, for in-depth news, financial data and graphs. By default the list is ordered by descending total market capitalization. Note that ETFs are usually tagged by ETFdb analysts as more than one type; for example, an inverse gold ETF may be tagged as “inverse” and as “gold” and as “commodity”.
As of 10/17/17